Broad Team Develop CRISPR-Cas13 Combination Diagnostic-Antiviral

Scientists led by a team at the Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard now report on the development of a...
Single-gene testing just isn't adequate anymore

Why the Controversy? Start Sequencing Tumor Genes at Diagnosis

There are huge benefits to genomic tumor assessment, both for better treatment now, and later, if first-line treatments fail. But I don’t think many...
Source: aga7ta/Getty Images

Evogen Collaborates with UCB to Refine Epilepsy Seizure Diagnostic

The novel proteomics-based diagnostic seeks to provide a more accurate method to distinguish epileptic seizures from other medical events.
Electronic Health Record

Irish Researchers Integrate Epilepsy Genomics into Electronic Patient Records

Researchers in Ireland are one step closer to offering seamless personalized care to epilepsy patients nationwide, reporting that they have developed a genomics module...

Horizon, LGC Awarded Research Grant for Cancer Diagnostics

Horizon Discovery and LGC have been offered a research grant of £360,224 ($608,000) by the Technology Strategy Board, the U.K.’s innovation agency. The grant...
Nurse helping patient in hospital bed take a drink

Probiotic Drink Spiked with Genetic Elements Helps Thwart Antimicrobial Resistance

The drink targets small DNA elements called plasmids that carry antibiotic resistance genes. By preventing these plasmids from replicating, the antibiotic resistance genes are displaced, effectively re-sensitizing the bacteria to antibiotics.
Dendritic cell and T-lymphocytes, illustration

Johns Hopkins Researchers Refine TMB Calculations of Immunotherapy Response

The team developed a computational approach to estimate corrected TMB values for each tumor by simulating 20,000 tumors with various levels of TMB and sequencing coverage using information from the Cancer Genome Atlas to generate a correction factor for each simulated tumor based on its purity.
iGeneTRAIN has collected more than 30

Snapshot: Applying Genomics to Prevent Organ Rejection and Other Transplantation Complications

Over 650,000 solid organ transplants have been performed in the United States over the past three decades, and it is estimated that nearly 4...
MDxHealth and QUT bluebox say their planned liquid biopsy epigenetic assay will evaluate abnormal DNA methylation changes

MDxHealth, QUT Partner to Develop Oral Cancer Liquid Biopsy Assay

The saliva test will evaluate abnormal DNA methylation changes to indicate whether a patient may be at higher risk of developing cancer
Source: learn.genetics.utah.edu

Infant Airway Microbiome May Predict Future Lung Disorders

Researchers have discovered that an infant's airway is colonized by bacteria that could be predict of severe lung disease.
Scroll Up